Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-13
2010-11-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S303000, C514S266100, C514S266200, C514S266210, C514S266230, C514S266240, C514S326000, C514S255050, C514S278000, C540S567000, C544S235000, C544S405000, C546S118000, C546S209000, C546S017000
Reexamination Certificate
active
07834000
ABSTRACT:
The present invention relates to CGRP receptor antagonists, pharmaceutical compositions thereof, and methods therewith for treating CGRP receptor-mediated diseases and conditions.
REFERENCES:
patent: 7476665 (2009-01-01), Burgey et al.
patent: 03104236 (2003-12-01), None
patent: 2004017965 (2004-03-01), None
patent: 2004092166 (2004-10-01), None
patent: WO2007/146349 (2006-06-01), None
Recober, et al. Curr. Opin. Neurol. 22, pp. 241-246 (2009).
Hay, et al. Maturitas 64, pp. 104-108 (2009).
Yu, et al. Neurosci. and Biobehav. Rev. 33, pp. 1185-1191 (2009).
Schafer et al. Drug Discovery Today 2008, 13 (21/22), 913-916.
Horig et al. Journal of Translational Medicine 2004, 2(44).
PCT/US2007/013896: International Search Report dated Jul. 23, 2008.
Bergeron Daniele
Binch Hayley
Cao Jingrong
Come Jon
Gutierrez Corey
Badia Michael C.
Barker Michael
Saeed Kamal A
Vertex Pharmaceuticals Incorporated
LandOfFree
CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176620